AIM
ALKS icon

Acrospire Investment Management’s Alkermes ALKS Stock Holding History

Acrospire Investment Management’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-500
Closed -$29K – 51
2017
Q2 		$29K Buy
500
+300
+150% +$17.4K 0.03% 1300
2017
Q1 		$12K Sell
200
-900
-82% -$51K 0.01% 1816
2016
Q4 		$61K Buy
+1,100
New +$58.8K 0.03% 1266

Other funds holding ALKS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Acrospire Investment Management's ALKS Position: Q3 2017 in Review

Acrospire Investment Management sold out of Alkermes (ALKS) in Q3 2017, closing a stake of 500 shares — an estimated $29K sold.

Acrospire Investment Management first reported a position in ALKS in Q4 2016 and held it in 3 quarters. The position peaked at $61K in Q4 2016. 244 funds tracked by Wall St. Rank hold ALKS as of Q3 2017.

  • Acrospire Investment Management reported no remaining Alkermes position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 500 Alkermes shares in Q3 2017, an estimated $29K.
  • Acrospire Investment Management first reported a position in Alkermes in Q4 2016 and held it in 3 quarters.
  • Acrospire Investment Management's Alkermes position peaked at $61K in Q4 2016.
  • 244 funds tracked by Wall St. Rank held Alkermes as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.